دورية أكاديمية
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
العنوان: | Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1). |
---|---|
المؤلفون: | Hirsh V, Cadranel J, Cong XJ, Fairclough D, Finnern HW, Lorence RM, Miller VA, Palmer M, Yang JC, Hirsh, Vera, Cadranel, Jacques, Cong, Xiuyu Julie, Fairclough, Diane, Finnern, Henrik W, Lorence, Robert M, Miller, Vince A, Palmer, Michael, Yang, James Chih-Hsin |
المصدر: | Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, p229-237, 9p |
قاعدة البيانات: | Complementary Index |
كن أول من يترك تعليقا!